Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Standard Biotools (LAB) Interest Expenses (2016 - 2025)

Standard Biotools has reported Interest Expenses over the past 16 years, most recently at $5000.0 for Q4 2025.

  • Quarterly Interest Expenses fell 99.13% to $5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26000.0 through Dec 2025, down 99.22% year-over-year, with the annual reading at $26000.0 for FY2025, 99.22% down from the prior year.
  • Interest Expenses was $5000.0 for Q4 2025 at Standard Biotools, down from $10000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $1.2 million in Q3 2023 and troughed at $2000.0 in Q1 2025.
  • The 5-year median for Interest Expenses is $896000.0 (2021), against an average of $733315.8.
  • Year-over-year, Interest Expenses soared 1650.85% in 2024 and then tumbled 99.81% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $968000.0 in 2021, then grew by 22.93% to $1.2 million in 2022, then decreased by 7.73% to $1.1 million in 2023, then tumbled by 47.91% to $572000.0 in 2024, then crashed by 99.13% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Interest Expenses are $5000.0 (Q4 2025), $10000.0 (Q3 2025), and $9000.0 (Q2 2025).